{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:33:29Z","timestamp":1788982409218,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jinorgbio.2023.112127","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T19:59:59Z","timestamp":1674849599000},"page":"112127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The antihyperglycemic and hypolipidemic activities of a sulfur-oxidovanadium(IV) complex"],"prefix":"10.1016","volume":"241","author":[{"given":"Lidiane M.A.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.J.P.F.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eucilene K.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahoana","family":"Postal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Kostenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie C.","family":"Crans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner E.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica F.","family":"Belian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo C.","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2023.112127_bb0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2019"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0010","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4103\/2230-8210.183480","article-title":"Microvascular and macrovascular complications in diabetes mellitus: distinct or continuum?","volume":"20","author":"Chawla","year":"2016","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/diaclin.22.4.162","article-title":"Effects of glycemic control on diabetes complications and on the prevention of diabetes","volume":"22","author":"Skyler","year":"2004","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0025","article-title":"Metforminium decavanadate as a potential metallopharmaceutical drug for the treatment of diabetes mellitus","volume":"14","author":"Trevi\u00f1o","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jep.2015.05.043","article-title":"Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice","volume":"171","author":"Yang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrendo.2016.86","article-title":"Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus","volume":"12","author":"Tahrani","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4103\/0975-7406.90103","article-title":"Alternative therapies useful in the management of diabetes: a systematic review","volume":"3","author":"Pandey","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0050","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jinorgbio.2006.08.016","article-title":"Vanadium in diabetes: 100 years from phase 0 to phase I","volume":"100","author":"Thompson","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0026-0495(00)90418-9","article-title":"Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies","volume":"49","author":"Goldfine","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0060","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0026-0495(96)90013-X","article-title":"Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"45","author":"Boden","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0065","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1006\/bbrc.1993.2654","article-title":"Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats","volume":"197","author":"Thompson","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jinorgbio.2008.12.003","article-title":"Vanadium treatment of type 2 diabetes: a view to the future","volume":"103","author":"Thompson","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1211\/jpp.60.1.0013","article-title":"The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats","volume":"60","author":"Zhang","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0162-0134(00)00226-9","article-title":"Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovanadium(IV)","volume":"85","author":"Willsky","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-5491.2004.01381.x","article-title":"Insulin-mimetic and anti-diabetic effects of vanadium compounds","volume":"22","author":"Srivastava","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0090","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1039\/c3mt00162h","article-title":"Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients","volume":"5","author":"Willsky","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jinorgbio.2015.04.002","article-title":"Hypoglycemic, lipid-lowering and metabolic regulation activities of metforminium decavanadate (H2 Metf) 3[V10O28]\u00b78H2O using hypercaloric-induced carbohydrate and lipid deregulation in Wistar rats as biological model","volume":"147","author":"Trevi\u00f1o","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0162-0134(99)00152-X","article-title":"Vanadyl-biguanide complexes as potential synergistic insulin mimics","volume":"76","author":"Woo","year":"1999","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bjp.0702311","article-title":"Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats","volume":"126","author":"Reul","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/706074","article-title":"Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0115","first-page":"203","article-title":"Developing vanadium as an antidiabetic or anticancer drug: a clinical and historical perspective","volume":"19","author":"Crans","year":"2019","journal-title":"Met. Ions Life Sci."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0120","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/molecules22122269","article-title":"Vanadium compounds as PTP inhibitors","volume":"22","author":"Irving","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00775-001-0311-5","article-title":"In vitro study of the insulin-mimetic behaviour of vanadium (IV, V) coordination compounds","volume":"7","author":"Rehder","year":"2002","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jinorgbio.2015.03.004","article-title":"Thirty years through vanadium chemistry","volume":"147","author":"Pessoa","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0020-1693(03)00430-4","article-title":"Vanadium(IV) and vanadium(V) complexes of dipicolinic acid and derivatives. Synthesis, X-ray structure, solution state properties and effects in rats with STZ-induced diabetes","volume":"356","author":"Crans","year":"2003","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1039\/B815384C","article-title":"Glucose lowering activity by oral administration of bis(allixinato)oxidovanadium(IV) complex in streptozotocin-induced diabetic mice and gene expression profiling in their skeletal muscles","volume":"1","author":"Hiromura","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0145","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1039\/c2dt30521f","article-title":"The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains","volume":"41","author":"Winter","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0150","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jinorgbio.2008.11.001","article-title":"Aminoacid-derivatised picolinato-oxidovanadium(IV) complexes: characterization, speciation, and ex vivo insulin-mimetic potential","volume":"103","author":"Esbak","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0155","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jinorgbio.2011.05.008","article-title":"A new salicylic acid-derivatized kojic acid vanadyl complex: synthesis, characterization and anti-diabetic therapeutic potential","volume":"105","author":"Wei","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2014.07.003","article-title":"The structural basis of action of vanadyl (VO2+) chelates in cells","volume":"279","author":"Makinen","year":"2014","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0165","article-title":"Vanadium(IV)-diamine complex with hypoglycemic activity and a reduction in testicular atrophy","volume":"216","author":"Lima","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0162-0134(00)00045-3","article-title":"An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats","volume":"80","author":"Sakurai","year":"2000","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0175","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1246\/cl.1999.913","article-title":"A new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) coordination mode","volume":"28","author":"Sakurai","year":"1999","journal-title":"Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0180","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1246\/cl.2004.1274","article-title":"Insulinomimetic vanadyl-hydroxythiazolethione complexes with VO(S2O2) coordination mode: the correlation between the activity and Hammett\u2019s substituent constant","volume":"33","author":"Katoh","year":"2004","journal-title":"Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0185","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jinorgbio.2004.09.013","article-title":"Vanadium(III) complexes with L-cysteine - stability, speciation and the effect on actin in hepatoma Morris 5123 cells","volume":"98","author":"Osi\u0144ska-Kr\u00f3licka","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0190","first-page":"241","article-title":"Medicinal aspects of vanadium complexes: treatment of diabetes mellitus in model animals","volume":"18","author":"Sakurai","year":"2007","journal-title":"Biomed. Res. Trace Elem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0195","first-page":"752","article-title":"Platinum(II) complexes conjugated and analogous to O-glycosides: synthesis, structural characterization, and antitumor activity","volume":"43","author":"Lima","year":"2020","journal-title":"Quim Nova"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0200","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/ja00164a009","article-title":"Application of time-resolved vanadium-51 2D NMR for quantitation of kinetic exchange pathways between vanadate monomer, dimer, tetramer, and pentamer","volume":"112","author":"Crans","year":"1990","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccr.2014.10.014","article-title":"High-frequency and field electron paramagnetic resonance of vanadium (IV, III, and II) complexes","volume":"301\u2013302","author":"Krzystek","year":"2015","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0210","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/ic00120a029","article-title":"Structural and EPR studies of vanadium complexes of deprotonated amide ligands: effects on the 51V hyperfine coupling constant","volume":"34","author":"Cornman","year":"1995","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/ic9905897","article-title":"Chemistry and insulin mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives","volume":"39","author":"Amin","year":"2000","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0220","article-title":"Interaction of V(V) complexes formed by picolinic and pyrazinecarboxylic acid derivatives with red blood cells","volume":"212","author":"Sanna","year":"2021","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ica.2013.12.038","article-title":"Uptake of potential anti-diabetic (VO)-O-IV compounds of picolinate ligands by red blood cells","volume":"420","author":"Sanna","year":"2014","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jinorgbio.2014.12.021","article-title":"Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone","volume":"147","author":"Sanna","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0235","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2017.01.002","article-title":"Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities","volume":"352","author":"Levina","year":"2017","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0240","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US)","year":"2011"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0245","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.biopha.2018.02.137","article-title":"Animal models and natural products to investigate in vivo and in vitro antidiabetic activity","volume":"101","author":"Hasan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0250","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1590\/0001-3765201620160041","article-title":"Acute toxicity and cytotoxicity effect of ethanolic extract of Spondias tuberose arruda bark: hematological, biochemical and histopathological evaluation","volume":"88","author":"Barbosa","year":"2016","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0255","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4314\/ijs.v20i1.4","article-title":"A comparative analysis of glucose oxidase method and three point-of-care measuring devices for glucose determination","volume":"20","author":"Ekun","year":"2018","journal-title":"IFE J. Sci."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0260","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11010-005-9107-1","article-title":"Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats","volume":"286","author":"Yanardag","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0265","doi-asserted-by":"crossref","DOI":"10.5935\/1676-2444.20200003","article-title":"Martin\u2019s, Friedewald\u2019s and Cordova\u2019s formulas compared to LDL-C directly measured in southern Brazil","volume":"56","author":"Cordova","year":"2020","journal-title":"J. Bras. Patol. Med. Lab."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0270","article-title":"Antiobesity and hypoglycaemic effects of aqueous extract of ibervillea sonorae in mice fed a high-fat diet with fructose","volume":"2011","author":"Rivera-Ram\u00edrez","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0275","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0021-9258(18)65284-6","article-title":"The determination of glycogen in liver and muscle by use of anthrone reagent","volume":"220","author":"Carroll","year":"1956","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/BTER:104:3:233","article-title":"Effects of vanadyl sulfate on the liver of streptozotocin-induced diabetic rats","volume":"104","author":"Koyuturk","year":"2005","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0285","first-page":"1410","article-title":"Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes","volume":"86","author":"Cusi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.phrs.2005.12.004","article-title":"Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats","volume":"53","author":"Tunali","year":"2006","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.jinorgbio.2023.112127_bb0295","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.jinorgbio.2005.08.014","article-title":"Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes","volume":"99","author":"Delgado","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jinorgbio.2013.11.005","article-title":"Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats","volume":"131","author":"Domingues","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jinorgbio.2015.11.004","article-title":"In vitro effects of bis(1,2-dimethyl-3-hydroxy-4-pyridinonato)oxo-vanadium (IV), or VO(dmpp)2, on insulin secretion in pancreatic islets of type 2 diabetic Goto-Kakizaki rats","volume":"154","author":"Pelletier","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0310","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10534-009-9241-4","article-title":"Anti-diabetic effects of vanadium(III, IV, V)\u2013chlorodipicolinate complexes in streptozotocin-induced diabetic rats","volume":"22","author":"Li","year":"2009","journal-title":"BioMetals"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0315","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0320","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/db10-1032","article-title":"Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy","volume":"59","author":"Rizza","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2005.12.028","article-title":"Effects of bis(\u03b1-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats","volume":"368","author":"Gao","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jinorgbio.2014.03.011","article-title":"Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats","volume":"136","author":"Xie","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0335","series-title":"Treasure Island (FL)","article-title":"Biochemistry, insulin metabolic effects","author":"Vargas","year":"2020"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0340","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0345","first-page":"64","article-title":"AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice","volume":"52","author":"Dobi\u00e1sov\u00e1","year":"2006","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","article-title":"Pathogenesis of lipid disorders in insulin resistance: a brief review","volume":"18","author":"Bjornstad","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-005-6988-y","article-title":"Amelioration of diabetic dyslipidemia by macrocyclic binuclear oxovanadium complex on streptozotocin induced diabetic rats","volume":"272","author":"Ramachandran","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0162-0134(01)00192-1","article-title":"Amelioration of insulin resistance in diabetic ob\/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) coordination mode","volume":"85","author":"Takeshita","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0365","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jinorgbio.2012.06.001","article-title":"VO(dmpp)2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy","volume":"115","author":"Metelo","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0370","doi-asserted-by":"crossref","first-page":"17841","DOI":"10.1039\/C9NJ02491C","article-title":"Metabolic effects of VO(dmpp)2 \u2013 an ex vivo 1H-HRMAS NMR study to unveil its pharmacological properties","volume":"43","author":"Metelo","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0375","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18295\/squmj.2016.16.02.002","article-title":"Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation","volume":"16","author":"Mohamed","year":"2016","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0380","first-page":"835","article-title":"Risks of rapid decline renal function in patients with type 2 diabetes","volume":"15","author":"Jing Heen","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0385","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1007075204494","article-title":"Anti-diabetic and toxic effects of vanadium compounds","volume":"206","author":"Srivastava","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0390","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902019000318586","article-title":"Evaluating the effects of vanadyl sulfate on biomarkers of oxidative stress and inflammation in renal tissue of rats with diabetes type 2","volume":"56","author":"Fereshteh","year":"2020","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0395","article-title":"The renal effects of vanadate exposure: potential biomarkers and oxidative stress as a mechanism of functional renal disorders-preliminary studies","volume":"2014","author":"Ucibior","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0400","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00204-005-0663-7","article-title":"Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats","volume":"79","author":"Saad","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0405","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-4274(98)00385-3","article-title":"Effect of age on vanadium nephrotoxicity in rats","volume":"105","author":"Torre","year":"1999","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0410","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.2174\/0929867323666160321121138","article-title":"Why antidiabetic vanadium complexes are not in the pipeline of \u201cbig pharma\u201d drug research? A critical review","volume":"23","author":"Scior","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0415","first-page":"995","article-title":"Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review, mini-reviews","volume":"5","author":"Scior","year":"2005","journal-title":"Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0420","doi-asserted-by":"crossref","first-page":"17603","DOI":"10.1039\/C9NJ01638D","article-title":"In vitro experiments and infrared spectroscopy analysis of acid and alkaline phosphatase inhibition by vanadium complexes","volume":"43","author":"Parente","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0425","doi-asserted-by":"crossref","first-page":"114955","DOI":"10.1039\/C6RA15826A","article-title":"Chemoprotective activity of mixed-valence polyoxovanadates against diethylsulphate in E. coli cultures: insights from solution speciation studies","volume":"6","author":"Postal","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0430","article-title":"Reactivity and speciation of anti-diabetic vanadium complexes in whole blood and its components: the important role of red","author":"Levina","year":"2015","journal-title":"Blood Cells"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0435","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jinorgbio.2016.09.013","article-title":"Selective speciation improves efficacy and lowers the toxicity of platinum anticancer and vanadium antidiabetic drugs","volume":"165","author":"Doucette","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110873","article-title":"Effects of vanadium (IV) compounds on plasma membrane lipids lead to G protein-coupled receptor signal transduction","volume":"203","author":"Althumairy","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0162-0134(03)00090-4","article-title":"Vanadium(IV\/V) speciation of pyridine-2,6-dicarboxylic acid and 4-hydroxy-pyridine-2,6-dicarboxylic acid complexes: potentiometry, EPR spectroscopy and comparison across oxidation states","volume":"95","author":"Jakusch","year":"2003","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0450","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jinorgbio.2008.11.010","article-title":"Decavanadate (V10O286\u2212) and oxovanadates: oxometalates with many biological activities","volume":"103","author":"Aureliano","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0455","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/ic50154a006","article-title":"Nature of vanadium(IV) in basic aqueous solution","volume":"14","author":"Iannuzzi","year":"1975","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0460","first-page":"304","article-title":"Application of NMR spectroscopy to studies of aqueous coordination chemistry of vanadium(V) complexes","volume":"246","author":"Crans","year":"1996","journal-title":"Mech. Bioinorg. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0465","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/ja00083a016","article-title":"Characterization of vanadium (V) complexes in aqueous solutions: ethanolamine- and glycine-derived complexes","volume":"116","author":"Crans","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0470","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jinorgbio.2014.12.014","article-title":"The (biological) speciation of vanadate(V) as revealed by 51V NMR: a tribute on Lage Pettersson and his work","volume":"147","author":"Rehder","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0475","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0020-1693(03)00473-0","article-title":"Study of the oxidation products of the VO(dmpp)2 complex in aqueous solution under aerobic conditions: comparison with the vanadate\u2013dmpp system","volume":"356","author":"Castro","year":"2003","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0480","doi-asserted-by":"crossref","first-page":"8108713","DOI":"10.1155\/2018\/8108713","article-title":"A novel oxidovanadium (IV)-orotate complex as an alternative antidiabetic agent: synthesis, characterization, and biological assessments","volume":"2018","author":"Naglah","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jinorgbio.2023.112127_bb0485","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10534-006-9005-3","article-title":"Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: a pragmatic therapeutic approach for diabetes","volume":"19","author":"Shukla","year":"2006","journal-title":"BioMetals"}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013423000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013423000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:10:10Z","timestamp":1758985810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013423000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":97,"alternative-id":["S0162013423000090"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112127","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antihyperglycemic and hypolipidemic activities of a sulfur-oxidovanadium(IV) complex","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112127"}}